[go: up one dir, main page]

WO2009047800A3 - Oral controlled release composition of carvedilol - Google Patents

Oral controlled release composition of carvedilol Download PDF

Info

Publication number
WO2009047800A3
WO2009047800A3 PCT/IN2008/000652 IN2008000652W WO2009047800A3 WO 2009047800 A3 WO2009047800 A3 WO 2009047800A3 IN 2008000652 W IN2008000652 W IN 2008000652W WO 2009047800 A3 WO2009047800 A3 WO 2009047800A3
Authority
WO
WIPO (PCT)
Prior art keywords
carvedilol
controlled release
oral controlled
pharmaceutically acceptable
release composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2008/000652
Other languages
French (fr)
Other versions
WO2009047800A2 (en
Inventor
Ashish Guha
Bharat Metkar
Makrand Krishnakumar Avachat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lupin Ltd
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of WO2009047800A2 publication Critical patent/WO2009047800A2/en
Publication of WO2009047800A3 publication Critical patent/WO2009047800A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

An oral controlled release pharmaceutical composition comprising a carvedilol or a pharmaceutically acceptable salt(s) thereof. The oral controlled release pharmaceutical composition comprises a core comprising a therapeutically effective amount of carvedilol or a pharmaceutically acceptable salt(s) thereof and/or other pharmaceutically acceptable excipient thereof; and a functional coating comprising one or more pH dependent polymer(s), water soluble pore forming agent and/or other pharmaceutically acceptable excipient(s) thereof.
PCT/IN2008/000652 2007-10-09 2008-10-08 Oral controlled release composition of carvedilol Ceased WO2009047800A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1385KO2007 2007-10-09
IN1385/KOL/2007 2007-10-09

Publications (2)

Publication Number Publication Date
WO2009047800A2 WO2009047800A2 (en) 2009-04-16
WO2009047800A3 true WO2009047800A3 (en) 2009-08-13

Family

ID=40275982

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000652 Ceased WO2009047800A2 (en) 2007-10-09 2008-10-08 Oral controlled release composition of carvedilol

Country Status (1)

Country Link
WO (1) WO2009047800A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110229564A1 (en) * 2010-03-22 2011-09-22 Amneal Pharmaceuticals, L.L.C. Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040019096A1 (en) * 2001-10-23 2004-01-29 Vlassios Andronis Novel formulations of carvedilol
WO2004056336A2 (en) * 2002-12-20 2004-07-08 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems
US20050175695A1 (en) * 2003-11-25 2005-08-11 Catherine Castan Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
WO2006044202A2 (en) * 2004-10-19 2006-04-27 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Enteric coated compositions that release active ingredient(s) in gastric fluid and intestinal fluid
WO2007023325A2 (en) * 2005-08-26 2007-03-01 Egis Gyógyszergyár Nylvánosan Müködo Részvénytársaság Controlled release pharmaceutical composition containing carvedilol
WO2008070072A2 (en) * 2006-12-01 2008-06-12 Mutual Pharmaceutical Company, Inc. Carvedilol forms, compositions, and methods of preparation thereof
WO2008083130A2 (en) * 2006-12-26 2008-07-10 Dr. Reddy's Laboratories Limited Amorphous and crystalline form a of carvedilol phosphate

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040019096A1 (en) * 2001-10-23 2004-01-29 Vlassios Andronis Novel formulations of carvedilol
WO2004056336A2 (en) * 2002-12-20 2004-07-08 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems
US20050175695A1 (en) * 2003-11-25 2005-08-11 Catherine Castan Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
WO2006044202A2 (en) * 2004-10-19 2006-04-27 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Enteric coated compositions that release active ingredient(s) in gastric fluid and intestinal fluid
WO2007023325A2 (en) * 2005-08-26 2007-03-01 Egis Gyógyszergyár Nylvánosan Müködo Részvénytársaság Controlled release pharmaceutical composition containing carvedilol
WO2008070072A2 (en) * 2006-12-01 2008-06-12 Mutual Pharmaceutical Company, Inc. Carvedilol forms, compositions, and methods of preparation thereof
WO2008083130A2 (en) * 2006-12-26 2008-07-10 Dr. Reddy's Laboratories Limited Amorphous and crystalline form a of carvedilol phosphate

Also Published As

Publication number Publication date
WO2009047800A2 (en) 2009-04-16

Similar Documents

Publication Publication Date Title
WO2007133583A3 (en) Zero-order modified release solid dosage forms
WO2008022932A3 (en) Controlled release system and method for manufacturing the same
WO2007054976A3 (en) Lipid based controlled release pharmaceutical composition
WO2008081891A1 (en) Orally disintegrating solid preparation
WO2010037854A3 (en) Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules
WO2009055306A3 (en) Coating designs for the tailored release of dual drugs from polymeric coatings
WO2011084618A3 (en) Compositions and methods for oral drug delivery
WO2007036952A3 (en) Novel sustained release dosage form
WO2006039499A3 (en) Method for improving the biovailability of orally delivered therapeutics
WO2010015567A3 (en) Controlled release formulations using intelligent polymers
WO2009047802A3 (en) Novel colon targeted modified release bioadhesive formulation of 5-amino salicylic acid or its salts and metabolites thereof
WO2007135193A3 (en) Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means
WO2007109057A3 (en) Solid dosage form containing a taste masked active agent
WO2007144169A3 (en) Entacapone-derivatives
WO2006082523A3 (en) Pharmaceutical sustained release composition of metformin
WO2007025005A3 (en) Sustained release formulations of nalbuphine
WO2008084698A1 (en) Tacrolimus sustained release pharmaceutical composition
WO2012022919A3 (en) Nalbuphine-based formulations and uses thereof
WO2009057138A3 (en) Controlled release pharmaceutical compositions of tolterodine
WO2011037976A3 (en) Pramipexole pharmaceutical formulations
WO2009072334A1 (en) Core particle for pharmaceutical preparation
WO2009149058A3 (en) Modified release niacin formulations
WO2007110753A3 (en) Extended release dosage forms of metoprolol
WO2009023761A3 (en) Pharmaceutical compositions comprising ropinirole
WO2010046932A3 (en) Extended release pharmaceutical composition of minocycline and process thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08837487

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08837487

Country of ref document: EP

Kind code of ref document: A2